V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008404 | 280005590 | 1.8 | 71 | null | 2017-11-19 | 2017-12-10 | DOXORUBICIN | N | N | 280027445 | DOXORUBICIN |
| 280008405 | 280005591 | 1.79 | 79.1 | Not known (9) | 2017-10-16 | 2017-10-16 | Paclitaxel 7 day | Y | N | 280027459 | PACLITAXEL |
| 280008406 | 280005592 | 1.67 | 28.4 | null | 2013-12-07 | 2013-12-17 | PACLITAXEL | N | N | 280027461 | PACLITAXEL |
| 280008407 | 280005593 | 1.6 | 74.3 | null | null | 2014-10-23 | Cisplatin | N | Y | 280027461 | CISPLATIN |
| 280008408 | 280005593 | 1.82 | 81.6 | null | 2015-08-23 | 2015-09-12 | Cetuximab + Radiotherapy Maint | Y | Y | 280027461 | CETUXIMAB + RT |
| 280008409 | 280005594 | null | 54.7 | Not known (9) | 2014-12-31 | 2015-01-21 | Cisplatin | N | N | 280027473 | CISPLATIN |
| 280008410 | 280005595 | 1.7 | 14.8 | Palliative (P) | 2018-04-18 | 2018-04-24 | Paclitaxel 7 day | null | null | 280027474 | PACLITAXEL |
| 280008411 | 280005597 | 1.85 | 64 | Adjuvant (A) | 2016-10-25 | 2016-11-05 | CARBOPLATIN + RT | null | null | 280027478 | CARBOPLATIN + RT |
| 280008412 | 280005598 | 1.6 | 56.1 | Palliative (P) | 2016-08-25 | 2016-09-15 | Cetuximab + Radiotherapy Maint | N | Y | 280027482 | CETUXIMAB + RT |
| 280008413 | 280005599 | 1.72 | 84.2 | Adjuvant (A) | 2014-07-05 | 2014-07-28 | DOXORUBICIN | N | N | 280027482 | DOXORUBICIN |
| 280008414 | 280005599 | 1.52 | 61.3 | Curative (C) | null | 2016-09-06 | CARBOPLATIN + RT | N | Y | 280027482 | CARBOPLATIN + RT |
| 280008415 | 280005600 | 1.63 | 52.3 | Adjuvant (A) | 2013-12-16 | 2013-12-30 | Cetuximab + Radiotherapy Maint | N | Y | 280027491 | CETUXIMAB + RT |
| 280008416 | 280008940 | null | null | Curative (C) | 2016-11-21 | 2016-11-22 | EW EuroEwing 99 : VIDE | N | N | 280027501 | EURO-EWING |
| 280008417 | 280005601 | 1.57 | null | null | 2017-12-21 | 2018-02-13 | DE-ESCALATE TRIAL | N | Y | 280027501 | DE-ESCALATE TRIAL |
| 280008418 | 280010552 | 1.59 | 106.4 | Curative (C) | 2017-08-03 | 2017-08-16 | EW EuroEwing 99 : VIDE | 2 | N | 280027518 | EURO-EWING |
| 280008419 | 280011333 | 1.63 | 78.3 | Palliative (P) | 2017-12-06 | 2017-12-22 | CISPLATIN + GEMCITABINE | 02 | N | 280027519 | CISPLATIN + GEMCITABINE |
| 280008420 | 280005602 | 1.83 | 62.6 | Palliative (P) | 2018-12-06 | 2018-12-06 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 280027523 | CISPLATIN + GEMCITABINE |
| 280008421 | 280005604 | 1.66 | 60.4 | Palliative (P) | 2013-06-21 | 2013-07-07 | Doxorubicin + Ifosfamide | 02 | N | 280027523 | DOXORUBICIN + IFOSFAMIDE |
| 280008422 | 280011334 | null | 35.9 | Curative (C) | 2017-12-18 | 2017-12-26 | VAI (Ifos 3g/m2) | N | N | 280027526 | IRINOTECAN + MDG |
| 280008423 | 280011721 | 1.6 | 91 | Palliative (P) | 2016-07-28 | 2016-08-02 | EURO-EWING | N | N | 280027530 | EURO-EWING |
| 280008424 | 280010554 | 1.78 | 92 | Adjuvant (A) | 2015-09-12 | 2015-09-12 | Doxorubicin + Ifosfamide | 02 | N | 280027534 | DOXORUBICIN + IFOSFAMIDE |
| 280008425 | 280005609 | 1.66 | 76 | Palliative (P) | 2014-06-21 | 2014-06-21 | Gemcitabine weekly | 02 | null | 280027535 | GEMCITABINE |
| 280008426 | 280005610 | 0 | 55.9 | Curative (C) | 2015-09-11 | 2016-08-28 | Carboplatin + Etoposide iv&po | 02 | N | 280027539 | CARBOPLATIN + ETOPOSIDE |
| 280008427 | 280005612 | 1.73 | 51.5 | Palliative (P) | 2015-07-19 | 2015-08-07 | VAI (Ifos 3g/m2) | 02 | N | 280027539 | VAI |
| 280008428 | 280005616 | 1.72 | 70 | Curative (C) | 2015-10-10 | 2015-10-15 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280027545 | CETUXIMAB + CISPLATIN + FU |
| 280008429 | 280005620 | 1.68 | 53.4 | Curative (C) | 2016-03-23 | 2016-03-23 | Irinotecan + Temozolomide | 02 | N | 280027549 | IRINOTECAN + TEMOZOLOMIDE |
| 280008430 | 280008947 | 1.82 | null | Palliative (P) | 2017-09-24 | 2017-10-02 | CARBOPLATIN + PACLITAXEL | 2 | N | 280027553 | CARBOPLATIN + PACLITAXEL |
| 280008431 | 280008947 | 1.75 | 81.6 | Palliative (P) | 2017-03-16 | 2017-07-05 | Doxorubicin + Ifosfamide | null | Y | 280027553 | DOXORUBICIN + IFOSFAMIDE |
| 280008432 | 280008947 | 1.61 | 79 | null | 2015-02-10 | 2015-02-11 | Doxorubicin + Ifosfamide | 2 | N | 280027553 | DOXORUBICIN + IFOSFAMIDE |
| 280008433 | 280005623 | 1.79 | 70 | Palliative (P) | 2014-02-10 | 2014-02-24 | Irinotecan + Temozolomide | N | N | 280027560 | VAI |
| 280008434 | 280005624 | 1.64 | 60.4 | Disease modification (D) | 2017-11-17 | 2017-12-29 | VAI (Ifos 3g/m2) | N | N | 280027560 | IRINOTECAN + TEMOZOLOMIDE |
| 280008435 | 280005624 | 1.81 | 70.6 | Curative (C) | null | 2014-10-28 | VAC | null | null | 280027560 | CAV |
| 280008436 | 280005624 | 1.79 | 93.7 | Curative (C) | 2016-10-31 | 2016-11-01 | VAC | N | Y | 280027560 | CAV |
| 280008437 | 280005628 | 1.68 | 92.2 | Palliative (P) | 2015-01-05 | 2015-01-06 | Irinotecan + Temozolomide | 02 | N | 280027586 | IRINOTECAN + MDG |
| 280008438 | 280008951 | 1.61 | 62.2 | Curative (C) | 2017-08-27 | 2017-09-15 | CISPLATIN + FLUOROURACIL | 02 | N | 280027588 | CISPLATIN + FLUOROURACIL |
| 280008439 | 280008951 | null | 72.2 | Curative (C) | 2015-05-23 | 2015-05-25 | CISPLATIN + FLUOROURACIL | 1 | N | 280027588 | CISPLATIN + FLUOROURACIL |
| 280008440 | 280005631 | 1.53 | null | Neo-adjuvant (N) | 2016-08-04 | 2016-08-16 | VAI (Ifos 3g/m2) | null | null | 280027591 | VAI |
| 280008441 | 280005632 | 2 | 36.2 | Palliative (P) | 2015-09-17 | 2015-09-17 | Carboplatin + Etoposide IV 3 day | N | N | 280027595 | CARBOPLATIN + ETOPOSIDE |
| 280008442 | 280005632 | 1.73 | 81 | Curative (C) | 2014-11-25 | 2014-11-25 | CARBOPLATIN + ETOPOSIDE | 02 | N | 280027595 | CARBOPLATIN + ETOPOSIDE |
| 280008443 | 280005633 | 1.76 | null | Curative (C) | 2013-10-09 | 2013-11-13 | CISPLATIN + FLUOROURACIL | N | null | 280027598 | CISPLATIN + FLUOROURACIL |
| 280008444 | 280008954 | 1.79 | 63.1 | Adjuvant (A) | 2017-07-19 | 2017-08-03 | Doxorubicin + Ifosfamide | N | N | 280027599 | DOXORUBICIN + IFOSFAMIDE |
| 280008445 | 280010560 | 1.6 | null | null | 2016-08-09 | 2016-09-07 | VAI (Ifos 3g/m2) | N | Y | 280027599 | VAI |
| 280008446 | 280005634 | 1.8 | 82.2 | Palliative (P) | 2018-08-27 | 2018-09-22 | CISPLATIN + FLUOROURACIL | 01 | N | 280027606 | CISPLATIN + FLUOROURACIL |
| 280008447 | 280005635 | 1.69 | 66 | Palliative (P) | 2017-04-12 | 2017-05-04 | Doxorubicin + Ifosfamide | N | N | 280027609 | DOXORUBICIN + IFOSFAMIDE |
| 280008448 | 280005639 | 1.87 | 73 | Palliative (P) | null | 2016-07-20 | VAI (Ifos 3g/m2) | N | N | 280027612 | IRINOTECAN + MDG |
| 280008449 | 280011339 | 1.77 | 75.6 | Palliative (P) | 2017-03-31 | 2017-04-07 | VAI (Ifos 3g/m2) | 02 | N | 280027612 | IRINOTECAN + TEMOZOLOMIDE |
| 280008450 | 280005640 | 1.73 | 76.2 | Palliative (P) | 2016-05-11 | 2016-09-08 | Doxorubicin + Olaratumab | Y | N | 280027614 | DOXORUBICIN + OLARATUMAB |
| 280008451 | 280005642 | 1.79 | 78.2 | null | null | 2016-08-22 | FLUOROURACIL + IRINOTECAN | 02 | N | 280027616 | IRINOTECAN + TEMOZOLOMIDE |
| 280008452 | 280005644 | 1.6 | 70 | Adjuvant (A) | 2016-04-14 | 2016-04-27 | DE-ESCALATE TRIAL | N | N | 280027619 | DE-ESCALATE TRIAL |
| 280008453 | 280008959 | 1.49 | 58.5 | Palliative (P) | 2014-12-14 | 2014-12-16 | Irinotecan + Modified De Gramont | 02 | N | 280027624 | IRINOTECAN + TEMOZOLOMIDE |